Abstract
Animal models have been vital to the development of allogeneic hematopoietic stem cell transplantation (AlloHSCT) as well as our understanding of its biology. Rodent models led the way in the demonstration of the whole body radiotherapy for effective anti-tumor responses [1] and the ability to rescue mice from high dose radiation with a transfusion of bone marrow cells [2, 3] in the early 1950s. However, the ability to promote prolonged tumor-free survival in mice using allogeneic bone marrow transplantation after myeloablative doses of radiation was offset by the recognition that allogeneic bone marrow transplant (BMT) could result in a lethal “secondary” disease of wasting, diarrhea and skin lesions [4] now known as graft-versus host disease. Interestingly, graft-versus-tumor (GVT) activity was also recognized in studies during this time period. [5, 6].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hollcroft J, Lorenz E, Hunstiger H (1950) Effects of ionizing radiations on a transplanted lymphosarcoma. J Natl Cancer Inst 11(1):1-16
Lorenz E, Congdon C, Uphoff D (1952) Modification of acute irradiation injury in mice and guinea-pigs by bone marrow injections. Radiology 58(6):863-877
Congdon CC, Uphoff D, Lorenz E (1952) Modification of acute irradiation injury in mice and guinea pigs by injection of bone marrow; a histopathologic study. J Natl Cancer Inst 13(1):73-107
Billingham RE (1959) Reactions of grafts against their hosts. Science 130:947-953
Reshchikov VP, Khoklova MP, Fertukhova HM (1961) The effect of homologous bone marrow transplantation on the course of the leukaemic process in mice with transplanted leukaemia. Probl Gematol Pereliv Krovi 6:593-599
Davis WE Jr, Cole LJ, Foley WA, Rosen VJ Jr (1963) Leukemia incidence and longevity in radiation-induced homologous mouse chimeras. Radiat Res 20:43-52
Storb R, Deeg HJ, Raff R et al (1995) Prevention of graft-versus-host disease. Studies in a canine model. Ann N Y Acad Sci 770:149-164
Epstein RB, Storb R, Clift RA, Thomas ED (1969) Transplantation of stored allogeneic bone marrow in dogs selected by histocompatibility typing. Transplantation 8(4):496-501
Eguchi H, Knosalla C, Lan P et al (2004) T cells from presensitized donors fail to cause graft-versus-host disease in a pig-to-mouse xenotransplantation model. Transplantation 78(11):1609-1617
Kozlowski T, Sablinski T, Basker M et al (2000) Decreased graft-versus-host disease after haplotype mismatched bone marrow allografts in miniature swine following interleukin-2 treatment. Bone Marrow Transplant 25(1):47-52
Srour EF, Zanjani ED, Brandt JE et al (1992) Sustained human hematopoiesis in sheep transplanted in utero during early gestation with fractionated adult human bone marrow cells. Blood 79(6):1404-1412
Panoskaltsis-Mortari A, Price A, Hermanson JR et al (2004) In vivo imaging of graft-versus-host-disease in mice. Blood 103(9):3590-3598
Beilhack A, Schulz S, Baker J et al (2005) In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 106(3):1113-1122
Cao YA, Bachmann MH, Beilhack A et al (2005) Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Transplantation 80(1):134-139
Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172(5):2731-2738
Hansen S, Leslie RG (2006) TGN1412: scrutinizing preclinical trials of antibody-based medicines. Nature 441(7091):282
Petrus MJ, Williams JF, Eckhaus MA, Gress RE, Fowler DH (2000) An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD. Biol Blood Marrow Transplant 6(2A):182-189
Luznik L, Jalla S, Engstrom LW, Iannone R, Fuchs EJ (2001) Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. Blood 98(12):3456-3464
Plunkett W, Saunders PP (1991) Metabolism and action of purine nucleoside analogs. Pharmacol Ther 49(3):239-268
Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL (1997) Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90(8):3204-3213
Paulos CM, Wrzesinski C, Kaiser A et al (2007) Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest 117(8):2197-2204
Claman HN, Jaffee BD, Huff JC, Clark RA (1985) Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol 94(1):73-84
Xun C, Thompson J, Jennings C, Brown S, Widmer M (1994) Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 83(8):2360-2367
Weiss L, Nusair S, Reich S, Sidi H, Slavin S (1996) Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia. Cancer Immunol Immunother 43(2):103-108
Sykes M, Szot GL, Swenson KA, Pearson DA (1997) Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 3(7):783-787
Truitt RL, Atasoylu AA (1991) Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood 77(11):2515-2523
Sprent J, Schaefer M, Gao EK, Korngold R (1988) Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts. J Exp Med 167(2):556-569
Anderson BE, McNiff J, Yan J et al (2003) Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 112(1):101-108
Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ (2004) Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood 103(4):1534-1541
Anderson BE, Taylor PA, McNiff JM et al (2008) Effects of donor T cell trafficking and priming site on GVHD induction by naive and memory phenotype CD4 T cells. Blood 111(10):5242-5251
Dutt S, Ermann J, Tseng D et al (2005) L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood 106(12):4009-4015
Petrovic A, Alpdogan O, Willis LM et al (2004) LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood 103(4):1542-1547
Beilhack A, Schulz S, Baker J et al (2008) Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood 111:2919-2928
Murai M, Yoneyama H, Ezaki T et al (2003) Peyer’s patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 4(2):154-160
Welniak LA, Kuprash DV, Tumanov AV et al (2006) Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation. Blood 107(1):410-412
Bennett M, Taylor PA, Austin M et al (1998) Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: influence of mouse colony environment. Int Immunol 10(6):785-790
Holler E, Rogler G, Brenmoehl J et al (2006) Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 107(10):4189-4193
Hill GR, Teshima T, Gerbitz A et al (1999) Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. J Clin Invest 104(4):459-467
Cooke KR, Gerbitz A, Crawford JM et al (2001) LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 107(12):1581-1589
Fitzgerald PA, Bennett M (1983) Aging of natural and acquired immunity of mice. I. Decreased natural killer cell function and hybrid resistance. Cancer Invest 1(1):15-24
Chen MG, Price GB, Makinodan T (1972) Incidence of delayed mortality (secondary disease) in allogeneic radiation chimeras receiving bone marrow from aged mice. J Immunol 108(5):1370-1378
Gorczynski RM, Kennedy M, MacRae S (1983) Alteration in lymphocyte recognition repertoire during aging. II. Changes in the expressed T-cell receptor repertoire in aged mice and the persistence of that change after transplantation to a new differentiative environment. Cell Immunol 75(2):226-241
Ordemann R, Hutchinson R, Friedman J et al (2002) Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 109(9):1249-1256
Cudkowicz G, Bennett M (1971) Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J Exp Med 134(6):1513-1528
Cudkowicz G, Bennett M (1971) Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med 134(1):83-102
Haraguchi K, Takahashi T, Matsumoto A et al (2005) Host-residual invariant NK T cells attenuate graft-versus-host immunity. J Immunol 175(2):1320-1328
Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA (1991) In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment. J Immunol 147(5):1492-1503
Slavin S, Reitz B, Bieber CP, Kaplan HS, Strober S (1978) Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts. J Exp Med 147(3):700-707
Soderling CC, Song CW, Blazar BR, Vallera DA (1985) A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants. J Immunol 135(2):941-946
Trambley J, Bingaman AW, Lin A et al (1999) Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 104(12):1715-1722
Aversa F, Tabilio A, Terenzi A et al (1994) Successful engraftment of T-cell-depleted haploidentical 3-loci incompatible transplants in leukemia patients by addition of recombinant human granulocyte-colony-stimulating factor-mobilized peripheral-blood progenitor cells to bone-marrow inoculum. Blood 84(11):3948-3955
Bachar-Lustig E, Rachamim N, Li HW, Lan F, Reisner Y (1995) Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1(12):1268-1273
Martin PJ, Akatsuka Y, Hahne M, Sale G (1998) Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood 92(6):2177-2181
Graubert TA, Russell JH, Ley TJ (1996) The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 87(4):1232-1237
Sprent J, Surh CD, Agus D, Hurd M, Sutton S, Heath WR (1994) Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells. J Exp Med 180(1):307-317
Welniak LA, Blazar BR, Anver MR, Wiltrout RH, Murphy WJ (2002) Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning. Biol Blood Marrow Transplant 6:605-612
Komatsu M, Mammolenti M, Jones M, Jurecic R, Sayers TJ, Levy RB (2003) Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing. Blood 101(10):3991-3999
Taylor PA, Ehrhardt MJ, Roforth MM et al (2006) Mechanisms responsible for and strategies to overcome bone marrow (BM) rejection in allosensitized recipients. Submitted
Dulude G, Roy DC, Perreault C (1999) The effect of graft-versus-host disease on T cell production and homeostasis. J Exp Med 189(8):1329-1342
Weinberg K, Blazar BR, Wagner JE et al (2001) Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97(5):1458-1466
van den Brink MR, Moore E, Ferrara JL, Burakoff SJ (2000) Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation 69(3):446-449
Gendelman M, Yassai M, Tivol E, Krueger A, Gorski J, Drobyski WR (2003) Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution. Biol Blood Marrow Transplant 9(12):742-752
Brochu S, Rioux-Masse B, Roy J, Roy DC, Perreault C (1999) Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease. Blood 94(2):390-400
Chung B, Barbara-Burnham L, Barsky L, Weinberg K (2001) Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood 98(5):1601-1606
Mackall CL, Fleisher TA, Brown MR et al (1995) Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332(3):143-149
Mackall CL, Fleisher TA, Brown MR et al (1997) Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89(10):3700-3707
Panoskaltsis-Mortari A, Taylor PA, Rubin JS et al (2000) Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury. Blood 96(13):4350-4356
Min D, Taylor PA, Panoskaltsis-Mortari A et al (2002) Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99(12):4592-4600
Rossi S, Blazar BR, Farrell CL et al (2002) Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 100(2):682-691
Alpdogan O, Schmaltz C, Muriglan SJ et al (2001) Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98(7):2256-2265
Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K (1996) Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88(5):1887-1894
Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE (2001) IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97(5):1491-1497
Tan JT, Dudl E, LeRoy E et al (2001) IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 98(15):8732-8737
Alpdogan O, Muriglan SJ, Eng JM et al (2003) IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 112(7):1095-1107
Greenstein BD, Fitzpatrick FT, Adcock IM, Kendall MD, Wheeler MJ (1986) Reappearance of the thymus in old rats after orchidectomy: inhibition of regeneration by testosterone. J Endocrinol 110(3):417-422
Windmill KF, Meade BJ, Lee VW (1993) Effect of prepubertal gonadectomy and sex steroid treatment on the growth and lymphocyte populations of the rat thymus. Reprod Fertil Dev 5(1):73-81
Sutherland JS, Goldberg GL, Hammett MV et al (2005) Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 175(4):2741-2753
Chung B, Dudl E, Toyama A, Barsky L, Weinberg KI (2008) Importance of interleukin-7 in the development of experimental graft-versus-host disease. Biol Blood Marrow Transplant 14(1):16-27
Blaser BW, Roychowdhury S, Kim DJ et al (2005) Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood 105(2):894-901
Blaser BW, Schwind NR, Karol S et al (2006) Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft versus host disease but not for graft versus tumor activity. Blood 108(7):2463-2469
Billingham RE (1966) The biology of graft-versus-host reactions. Harvey Lect 62:21-78
Hess A, Thoburn C (1997) Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease. Immunol Rev 157:111-123
Korngold R, Marini JC, de Baca ME, Murphy GF, Giles-Komar J (2003) Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses. Biol Blood Marrow Transplant 9(5):292-303
Cooke KR, Hill GR, Gerbitz A et al (2000) Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 70(2):272-279
Schmaltz C, Alpdogan O, Muriglan SJ et al (2003) Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 101(6):2440-2445
Levine J, Paczesny S, Mineishi S et al (2008) Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease. Blood 111(4):2470-2475
Murphy WJ, Welniak LA, Taub DD et al (1998) Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 102(9):1742-1748
Yang YG, Qi J, Wang MG, Sykes M (2002) Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells. Blood 99(11):4207-4215
Jaffee BD, Claman HN (1983) Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol 77(1):1-12
DeClerck Y, Draper V, Parkman R (1986) Clonal analysis of murine graft-vs-host disease. II. Leukokines that stimulate fibroblast proliferation and collagen synthesis in graft-vs. host disease. J Immunol 136(10):3549-3552
Martin PJ, Pei J, Gooley T et al (2004) Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. Biol Blood Marrow Transplant 10(8):552-560
Anderson BE, McNiff JM, Matte C, Athanasiadis I, Shlomchik WD, Shlomchik MJ (2004) Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 104(5):1565-1573
Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL (2002) CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 196(3):401-406
Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196(3):389-399
Edinger M, Hoffmann P, Ermann J et al (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9(9):1144-1150
Taylor PA, Panoskaltsis-Mortari A, Swedin JM et al (2004) L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104(12):3804-3812
Hanash AM, Levy RB (2005) Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 105(4):1828-1836
Ermann J, Hoffmann P, Edinger M et al (2005) Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 105(5):2220-2226
Taylor PA, Noelle RJ, Blazar BR (2001) CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193(11):1311-1318
Zeiser RS, Nguyen VH, Beilhack A et al (2006) Inhibition of CD4+CD25+ regulatory T cell function by calcineurin dependent interleukin-2 production. Blood 108(1):390-399
Battaglia M, Stabilini A, Roncarolo MG (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105(12):4743-4748
Trenado A, Charlotte F, Fisson S et al (2003) Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 112(11):1688-1696
Barao I, Hanash AM, Hallett W et al (2006) Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc Natl Acad Sci USA 103(14):5460-5465
Xu H, Exner BG, Cramer DE, Tanner MK, Mueller YM, Ildstad ST (2002) CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow. J Immunol 168(4):1636-1643
Blazar BR, Taylor PA, Bluestone JA, Vallera DA (1996) Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens. Blood 87(10):4463-4472
Drobyski WR, Majewski D (1997) Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice. Blood 89(3):1100-1109
Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Barrett TA, Bluestone JA, Vallera DA (1996) Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens. Blood 87(2):827-837
Maeda Y, Reddy P, Lowler KP, Liu C, Bishop DK, Ferrara JL (2005) Critical role of host gammadelta T cells in experimental acute graft-versus-host disease. Blood 106(2):749-755
Barao I, Murphy WJ (2003) The immunobiology of natural killer cells and bone marrow allograft rejection. Biol Blood Marrow Transplant 9(12):727-741
Asai O, Longo DL, Tian ZG et al (1998) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 101(9):1835-1842
Zeng D, Lewis D, Dejbakhsh-Jones S et al (1999) Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 189(7):1073-1081
Lan F, Zeng D, Higuchi M, Huie P, Higgins JP, Strober S (2001) Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: “natural suppressor” cells. J Immunol 167(4):2087-2096
Baker J, Verneris MR, Ito M, Shizuru JA, Negrin RS (2001) Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood 97(10):2923-2931
Morris ES, MacDonald KP, Rowe V et al (2005) NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs. J Clin Invest 115(11):3093-3103
Acknowledgments.
The work from the authors’ laboratories was supported by NIH R01 CA93527, R01 HL089905, R01 CA102282 and R01 AG022661.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Welniak, L.A., Murphy, W.J. (2010). In Vivo Models of Allogeneic Hematopoietic Stem Cell Transplantation. In: Lazarus, H.M., Laughlin, M.J. (eds) Allogeneic Stem Cell Transplantation. Contemporary Hematology. Humana Press. https://doi.org/10.1007/978-1-59745-478-0_44
Download citation
DOI: https://doi.org/10.1007/978-1-59745-478-0_44
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-934115-33-6
Online ISBN: 978-1-59745-478-0
eBook Packages: MedicineMedicine (R0)